top of page
Latest News
Search
A New Single-Tablet Option for HIV's "Forgotten Population" Could Change Lives. Will Policy Let It?
New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?
Travis Roppolo
Mar 309 min read
The False Economy of Rationing Life
States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.
Travis Roppolo
Mar 235 min read
We Need Your Support Today!
bottom of page